Alogliptin Benzoate Patent Expiration

Alogliptin Benzoate is used for treating diabetes and associated disorders such as lipid and glucose metabolism issues. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Nesina on Jan 25, 2013.


Alogliptin Benzoate Patents

Given below is the list of patents protecting Alogliptin Benzoate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nesina US8697125 Tablet preparation without causing a tableting trouble Jun 16, 2029 Takeda Pharms Usa
Nesina US7807689 Dipeptidyl peptidase inhibitors Jun 27, 2028 Takeda Pharms Usa
Nesina US8173663 Dipeptidyl peptidase inhibitors Dec 02, 2025 Takeda Pharms Usa
Nesina US8288539 Dipeptidyl peptidase inhibitors Mar 15, 2025 Takeda Pharms Usa
Nesina US6890898 Method of regulating glucose metabolism, and reagents related thereto Feb 02, 2019

(Expired)

Takeda Pharms Usa
Nesina US7078381 Method of regulating glucose metabolism, and reagents related thereto Feb 02, 2019

(Expired)

Takeda Pharms Usa
Nesina US7459428 Method of regulating glucose metabolism, and reagents related thereto Feb 02, 2019

(Expired)

Takeda Pharms Usa
Nesina US6303661 Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals Apr 24, 2017

(Expired)

Takeda Pharms Usa
Nesina US6303640 Pharmaceutical composition Aug 09, 2016

(Expired)

Takeda Pharms Usa
Nesina US6150383 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Nesina US6211205 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Nesina US6329404 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa



Alogliptin Benzoate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List